![Page 2: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/2.jpg)
www.jointactionrarecancers.eu
![Page 3: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/3.jpg)
www.jointactionrarecancers.eu
![Page 4: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/4.jpg)
![Page 5: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/5.jpg)
![Page 6: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/6.jpg)
rare
diseases
cancerrare
cancers
![Page 7: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/7.jpg)
rarecancers
![Page 8: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/8.jpg)
Eur J Cancer 2011;47:2493
1. Pediatric cancers
2. Haematologic rare neoplasms
3. Sarcomas4. Rare thoracic cancers5. Neuroendocrine tumours6. Head & neck cancers7. Central nervous system tumours 8. Rare female genital cancers9. Rare urological and male genital tumours10. Endocrine gland tumours11. Digestive rare cancers12. Rare skin cancers & non-cutaneous melanoma
![Page 9: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/9.jpg)
Rare cancers…
childhood
![Page 10: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/10.jpg)
Rare cancers…
haematologicalchildhood
![Page 11: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/11.jpg)
Rare cancers…
childhoodhaematological
solid of the adult
![Page 12: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/12.jpg)
“Orphan drugs”
“unlikely that marketing would generate sufficient returns to justify the investment needed for development”
![Page 13: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/13.jpg)
EU «Orphan Regulation»
10-year marketing exclusivity fee reductions and exemptions specific scientific advice protocol assistance national incentives EU-funded research
![Page 14: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/14.jpg)
Registration & reimbursementrisk…
p
t
p
t
![Page 15: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/15.jpg)
![Page 16: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/16.jpg)
![Page 17: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/17.jpg)
![Page 18: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/18.jpg)
![Page 19: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/19.jpg)
* in 2017 RCE is also supported by Lilly and AbbVie
![Page 20: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/20.jpg)
17.
Call for increased integration of local, national and European centres of expertise into European reference networks, based on specific criteria as set out in the Commission’s proposed Directive on the application of patients’ rights in cross-border healthcare , in order to provide the necessary sound organisational structures for more efficient clinical research and early transfer of research data into clinical practice, thus improving the clinical management of rare cancers.
![Page 21: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/21.jpg)
![Page 22: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/22.jpg)
“will providehighly specialised healthcare for rare or low prevalence complex diseases or conditions”
![Page 23: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/23.jpg)
![Page 24: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/24.jpg)
promote good quality and safe care to patients by fostering properdiagnosis, treatment, follow-up and management of patientsacross the Network
empower and involve patients offer and promote multi-disciplinary advice for complex cases develop and implement clinical guidelines and cross-border patient
pathways exchange, gather and disseminate knowledge, evidence and
expertise within and outside the Network promote collaborative research within the Network reinforce research and epidemiological surveillance, through
setting up of shared registries exchange and disseminate knowledge and best practices, in
particular by supporting national centres and networks
![Page 25: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/25.jpg)
Objectives
With regard to RCs in the EU, to improve:1. Epidemiological surveillance2. Quality of care through ERNs3. Clinical practice guidelines4. Innovation5. Medical and Patient education6. Health policy measures7. Patient empowerement
![Page 26: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/26.jpg)
Work packages
WP
1 Coordination INT, IT2 Dissemination NKUA, GR3 Evaluation CSF, FI4 Epidemiology INT, IT
5 Assuring Quality of Care OECI
6 Clinical practice guidelines DKG, DE
7 Innovation and access to innovation WIV-ISP, BE
8 Medical education UP, HU
9 Childhood Cancers SIOPE10 Rare Cancer Policy ICO, ES
![Page 27: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/27.jpg)
18 MSs 34 ass. partners
![Page 28: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/28.jpg)
![Page 29: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/29.jpg)
![Page 30: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/30.jpg)
Distance case sharing
![Page 31: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/31.jpg)
![Page 32: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/32.jpg)
![Page 33: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/33.jpg)
![Page 34: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/34.jpg)
Big data & machine learning…
![Page 35: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/35.jpg)
![Page 36: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/36.jpg)
PLoS One 2015;10:e0141357
![Page 37: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/37.jpg)
«Big data» & knowledge generation…
R p<0.05
![Page 38: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/38.jpg)
Milan, 2018
Methodological implications(vs clinical trials!)
Technological windows ofopportunity
Added values for rare cancers
“BIG DATA, AI & RCs”
![Page 39: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/39.jpg)
Martinalbo J et alESMO 2016
![Page 40: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/40.jpg)
Martinalbo J et alESMO 2016
![Page 41: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/41.jpg)
London, June 30th 2016
![Page 42: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/42.jpg)
Adaptive licensing
“a prospectively planned processby which an early authorizationin a restricted patient populationis followed by iterative phasesof evidence-gathering and adaption of the marketing authorization to broader patient populations”
16 April 2018
![Page 43: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/43.jpg)
Oye KA et al. Clin Pharmacol Ther 2016;100:626
![Page 44: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/44.jpg)
The Bayesian probabilityin clinical research…
the probabilitythat a treatment is effective…
![Page 45: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/45.jpg)
The frequentist probabilityin clinical trials…
the probabilityyou had to find this differenceif there were no difference(null effect)…
p<0.05
![Page 46: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/46.jpg)
Mr. Bayes & Mr. Price. Phil Trans 1763;53:370
![Page 47: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/47.jpg)
P[A|B] = P[A] x P[B|A]P[B]
The Bayes theorem…
Mr. Bayes & Mr. Price. Phil Trans 1763;53:370
![Page 48: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/48.jpg)
J Natl Cancer Inst 2011;103:2
![Page 49: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/49.jpg)
Clinical decision-making Methods to combine evidence New study designs Surrogate end points Organization of studies
![Page 50: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/50.jpg)
London, October 3rd 2014
![Page 51: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/51.jpg)
London, April 30th 2015
![Page 52: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/52.jpg)
Pharma
Regulators
![Page 53: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/53.jpg)
Pharma
RegulatorsResearchers
![Page 54: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/54.jpg)
Pharma
RegulatorsResearchersPatients
![Page 55: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/55.jpg)
…….
![Page 56: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/56.jpg)
![Page 57: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/57.jpg)
![Page 58: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/58.jpg)
Frankfurt, 18 April 2017
SARCOMAS
![Page 59: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/59.jpg)
![Page 60: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/60.jpg)
![Page 61: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/61.jpg)
Approval vs reimbursement…
![Page 62: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/62.jpg)
![Page 63: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/63.jpg)
Pandora’s boxJ.W. Waterhouse - 1896
![Page 64: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/64.jpg)
Eur J Cancer 2011;47:2493
![Page 65: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/65.jpg)
Precision oncology…
![Page 66: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/66.jpg)
Precision medicine
![Page 67: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/67.jpg)
![Page 68: The Joint Action on Rare Cancers - CDDF | CDDF is the ...1. Pediatric cancers 2. Haematologic rare neoplasms 3. Sarcomas 4. Rare thoracic cancers 5. Neuroendocrine tumours 6. Head](https://reader034.vdocument.in/reader034/viewer/2022042417/5f3345356f5394730a3f7b29/html5/thumbnails/68.jpg)